Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
Glycogen storage disease type Ia (GSD Ia) is a rare inherited disease caused by mutations in the glucose-6-phosphatase (G6Pase) catalytic subunit gene (G6PC). Absence of G6Pase causes life-threatening hypoglycemia and long-term complications because of the accumulations of metabolic intermediates. B...
Main Authors: | Hye-Ri Kang, Lauren Waskowicz, Andrea M. Seifts, Dustin J. Landau, Sarah P. Young, Dwight D. Koeberl |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050119300191 |
Similar Items
-
Neonatal Glycogen Storage Disease Ia
by: Jinping Zhang, et al.
Published: (2015-02-01) -
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease
by: Hye-Ri Kang, et al.
Published: (2019-12-01) -
Recent development and gene therapy for glycogen storage disease type Ia
by: Janice Y. Chou, et al.
Published: (2017-09-01) -
Characterization of a canine model of glycogen storage disease type IIIa
by: Haiqing Yi, et al.
Published: (2012-11-01) -
Assessment of toxicity and biodistribution of recombinant AAV8 vector–mediated immunomodulatory gene therapy in mice with Pompe disease
by: Gensheng Wang, et al.
Published: (2014-01-01)